21, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced that it ...

Dr. Vivek Lall, Chief Executive of General Atomics Global Corporation, is a key advisor to the Trump Administration and a… India’s successful ground test of the Active Cooled Scramjet ...

The indoor season just started, but the Bruins are already making history. UCLA track and field competed at the Crossroads of America Invitational in Indianapolis on Friday and Saturday, where it ...

By uniting Huma's proven platform with Wheel's expertise in direct-to-patient virtual care, this collaboration brings a new level of accessibility, personalization, and insight to patient programs ...

Navi Mumbai metro line no. 1 will run every 10 minutes during peak hours from January 20, improving connectivity for commuters.

RSF pays tribute to the journalists and cartoonists killed and injured in the terrorist attack on the French satirical weekly Charlie Hebdo and points out that, ten years later, cartoonists and their ...

After hours: 7:06:22 p.m. EST ...

H.C. Wainwright has recently reiterated Humacyte Inc (HUMA) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 11, 2023, H.C. Wainwright had initiated ...